Loading clinical trials...
Loading clinical trials...
Provider Perspectives on Beta-lactam Therapeutic Drug Monitoring Programs in the Critically Ill: a Multicenter Mixed-methods Study
Conditions
Locations
3
United States
UF Health Shands
Gainesville, Florida, United States
Mayo Clinic
Rochester, Minnesota, United States
Royal Brisbane and Women's Hospital
Herston, Queensland, Australia
Start Date
October 22, 2020
Primary Completion Date
December 31, 2022
Completion Date
December 31, 2022
Last Updated
February 21, 2023
NCT07356583
NCT07188350
NCT07172451
NCT06667999
NCT07298720
NCT07478380
Lead Sponsor
Mayo Clinic
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions